Author: Jeff Erez

UBS Financial Services Inc. logo

In September 2018, a former client of UBS Financial Services Inc. settled a FINRA arbitration for $1.5 million for losses sustained from investment in VelocityShares 3x Long Crude ETN and Valeant Pharmaceutical International, Inc. The investor was a client of … Continue reading

Raymond James & Associates, Inc. logo

Erez Law is currently investigating former Raymond James Financial Services financial advisor Steve Reznik (CRD# 1067199) regarding recommendations and/or unauthorized purchases of risky biotech stocks such as: Achaogen, Acadia Pharmaceuticals, Celgene, Clovis, Gilead Sciences, and Ziopharm Oncology. Erez Law is … Continue reading

New Jersey Bureau of Securities within the Division of Consumer Affairs

Erez Law is currently investigating Ameriprise Financial Services financial advisors across the country regarding unsuitable alternative investments in client portfolios. In October 2018, Ameriprise Financial Services, Inc., based in Minneapolis and with branch offices in New Jersey, agreed to pay … Continue reading

centaurus financial inc

Erez Law is currently investigating Centaurus Financial, Inc. financial advisor Cindy Facin (CRD# 1015592) regarding inappropriate and unsuitable investment recommendations. Facin has been registered with Centaurus Financial, Inc. in Lexington, South Carolina since 2015. Facin has been the subject of … Continue reading

Future Income Payments

Erez Law is currently investigating former ProEquities, Inc. financial advisor Todd Phillips (CRD# 2948119) regarding recommendations to invest in Future Income Payments, LLC (FIP LLC) and related investments and insurance policies funded by FIP distributions. According to public records, a … Continue reading